At C100, we specialize in unlocking the full potential of intellectual property across the technology and life sciences landscapes. As a forward-thinking investment firm, we identify, fund, and accelerate high-value IP assets that drive innovation, improve lives, and reshape industries.

Our advisors brings together deep domain expertise in science and technology strategically evaluate and support groundbreaking ideas. Whether it's early-stage biotech platforms, emerging digital health technologies, or transformative software solutions, we provide the capital and strategic guidance necessary to turn intellectual property into real-world impact.

Our mission is to bridge the gap between innovation and market adoption—delivering long-term value for our partners, stakeholders, and society at large.

Innovation is our asset. Impact is our goal